Natasha Hansen supports life sciences organizations in developing evidence generation strategies and consulting on a wide range of vaccine policy issues.
Before joining Avalere, Natasha participated in a rotational leadership program with Merck’s global public policy office, where she supported the oncology and vaccine policy teams by conducting research and translating business priorities into policy strategies. Previously, she served as a research assistant at the National Cancer Institute, supporting research on cervical cancer screening technologies and human papillomavirus vaccines. She also served as a fellow at the US Agency for International Development’s Bureau of Global Health.
Natasha holds an MPH from Saint Louis University and a BA in international affairs and Spanish from Marquette University.